Anderson, P , Rothbaum, B. O., & Hodges, L. F. Virtual reality exposure in the treatment of social anxiety. Cognitive and Behavioral Practice, 10: 240-247, 2003.
APA Diagnostic and statistical manual of mental disorders, Fourth Edition - Text Revision (4th ed.): American Psychiatric Publishing, Inc. 2000.
Attkisson, C C. & Greenfield, T.K.The UCSF client satisfaction scales: I. The Client Satisfaction Questionnaire-8. In M.E. Maruish (Ed.), The use of psychological testing for treatment planning and outcomes assessment (2nd ed., pp. 1333-1346). Mahwah, NJ: Erlbaum. 1999.
Beck, A T., Steer, R. A., & Brown, G. K. (1996). Manual for Beck Depression Inventory - II. San Antonio, TX: The Psychological Corporation, Harcourt, Brace & Company.
Beidel, D C., Turner, S. M., Jacob, R. G., & Cooley, M. R. Assessment of social phobia: Reliability of an impromptu speech task. Journal of Anxiety Disorders, 3: 149-158, 1989.
Blöte AW, Kint MJ, Miers AC, Westenberg PM The relation between public speaking anxiety and social anxiety: a review. J Anxiety Disord. 2009 Apr;23(3):305-13. doi: 10.1016/j.janxdis.2008.11.007. Epub 2008 Nov 25. Review.
Borkovec, T D., & Nau, S. D. Credibility of analogue therapy rationales. Journal of Behavior Therapy and Experimental Psychiatry, 3: 257- 260, 1972.
Botella, C , Gallego, M. J., Garcia-Palacios, A., Baños, R. M., Quero, S., & Guillen, V. An internet-based self-help program for the treatment of fear of public speaking: A case study. Journal of Technology in Human Services, 26: 182-202, 2008.
Botella, C , García-Palacios, A., Villa, H., Baños, R. M., Quero, S., Alcañiz, M., & Riva, G. Virtual reality exposure in the treatment of panic disorder and agoraphobia: A controlled study. Clinical Psychology & Psychotherapy, 14: 164-175, 2007.
Bouchard, S , Dumoulin, S., Robillard, G., Guitard, T. & Klinger, E. et al. A randomized control trial for the use of in virtuo exposure in the treatment of social phobia: final results. Journal of CyberTherapy and Rehabilitation, 4: 197-199, 2011.
Bouton, M E., Woods, A. M., Moody, E. W., Sunsay, C., & Garcia-Guitierrez, A. (2006). Counteracting the context-dependence of extinction: Relapse and some tests of possible methods of relapse prevention. In M. G. Craske, D. Hermans, & D. Vansteenwegen (Eds.), Fear and learning: Basic science to clinical application. (pp.175-196). Washington, DC: American Psychological Association.
Busseri MA, Tyler JD Interchangeability of the Working Alliance Inventory and Working Alliance Inventory, Short Form. Psychol Assess. 2003 Jun;15(2):193-7.
Clark, D M., & Wells, A. (1995). A cognitive model of social phobia. In R. G. Heimberg, M. R. Liebowitz, D. A. Hope, & F. R. Schneier (Eds.), Social phobia: Diagnosis, assessment, and treatment (pp. 69-93). New York: Guilford Press.
Emmelkamp PM Technological innovations in clinical assessment and psychotherapy. Psychother Psychosom. 2005;74(6):336-43. Review.
Feingold A Effect sizes for growth-modeling analysis for controlled clinical trials in the same metric as for classical analysis. Psychol Methods. 2009 Mar;14(1):43-53. doi: 10.1037/a0014699.
First, M B., Spitzer, R. L., Gibbon, M., & Williams, J. B. W. (1994). Structured Clinical Interview for Axis I DSM-IV Disorders—Research Edition. New York, NY: Biometrics Research Department.
Guy, W (1976) ECDEU Assessment Manual for Psychotherapy - Revised (DHEW Publication No. ADM 76-338). Bethesda, MD: National Institute of Mental Health.
Hofmann SG, Dibartolo PM An instrument to assess self-statements during public speaking: scale development and preliminary psychometric properties. Behav Ther. 2000;31(3):499-515.
Hofmann SG Cognitive factors that maintain social anxiety disorder: a comprehensive model and its treatment implications. Cogn Behav Ther. 2007;36(4):193-209. Review.
Hofmann SG Cognitive mediation of treatment change in social phobia. J Consult Clin Psychol. 2004 Jun;72(3):393-9.
Horvath, A O., & Greenberg, L. S. Development and validation of the Working Alliance Inventory. Journal of Counseling Psychology, 36: 223-233, 1989.
Klorman, R , Weerts, T. C., Hastings, J. E., Melamed, B. G., & Lang, P. J. Psychometric description of some specific-fear questionnaires. Behavior Therapy, 5: 401-409, 1974.
Leary, M R. A brief version of the Fear of Negative Evaluation Scale. Personality and Social Psychology Bulletin, 9: 371- 375, 1983.
McCroskey, J C. Validity of the PRCA as an index of oral communication apprehension. Communication Monographs, 45: 192-203, 1978.
Meyerbröker K, Emmelkamp PM Virtual reality exposure therapy in anxiety disorders: a systematic review of process-and-outcome studies. Depress Anxiety. 2010 Oct;27(10):933-44. doi: 10.1002/da.20734. Review.
Meyerbroker, K , & Emmelkamp, P. M. G. Therapeutic processes in virtual reality exposure therapy: The role of cognitions and the therapeutic alliance. Journal of Cyber Therapy and Rehabilitation, 1: 247-257, 2008.
Muthén, L K., & Muthén, B. O. (2012). Mplus user's guide (6th ed.). Los Angeles, CA: Muthén & Muthén.
Otto, M W., Smits, J. A. J., & Reese, H. E. Combined psychotherapy and pharmacotherapy for mood and anxiety disorders in adults: Review and analysis. Clinical Psychology: Science and Practice, 12: 72-86, 2005.
Parsons TD, Rizzo AA Affective outcomes of virtual reality exposure therapy for anxiety and specific phobias: a meta-analysis. J Behav Ther Exp Psychiatry. 2008 Sep;39(3):250-61. Epub 2007 Jul 25.
Paul, G L. (1966). Insight vs desensitization in psychotherapy. Standford, CA: Stanford University Press.
Rapee RM, Gaston JE, Abbott MJ Testing the efficacy of theoretically derived improvements in the treatment of social phobia. J Consult Clin Psychol. 2009 Apr;77(2):317-27. doi: 10.1037/a0014800.
Raudenbush SW, Xiao-Feng L Effects of study duration, frequency of observation, and sample size on power in studies of group differences in polynomial change. Psychol Methods. 2001 Dec;6(4):387-401.
Raudenbush, S W. and Bryk, A.S. (2002). Hierarchical Linear Models (Second Edition). Thousand Oaks: Sage Publications.
Safir MP, Wallach HS, Bar-Zvi M Virtual reality cognitive-behavior therapy for public speaking anxiety: one-year follow-up. Behav Modif. 2012 Mar;36(2):235-46. doi: 10.1177/0145445511429999. Epub 2011 Dec 15.
Schulz KF, Altman DG, Moher D; CONSORT Group CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomised trials. J Clin Epidemiol. 2010 Aug;63(8):834-40. doi: 10.1016/j.jclinepi.2010.02.005. Epub 2010 Mar 25.
Shiban Y, Pauli P, Mühlberger A Effect of multiple context exposure on renewal in spider phobia. Behav Res Ther. 2013 Feb;51(2):68-74. doi: 10.1016/j.brat.2012.10.007. Epub 2012 Nov 11.
Taylor CT, Alden LE Safety behaviors and judgmental biases in social anxiety disorder. Behav Res Ther. 2010 Mar;48(3):226-37. doi: 10.1016/j.brat.2009.11.005. Epub 2009 Nov 18.
Van Breukelen GJ ANCOVA versus change from baseline: more power in randomized studies, more bias in nonrandomized studies [corrected]. J Clin Epidemiol. 2006 Sep;59(9):920-5. Epub 2006 Jun 23. Erratum in: J Clin Epidemiol. 2006 Dec;59(12):1334.
Wallach HS, Safir MP, Bar-Zvi M Virtual reality cognitive behavior therapy for public speaking anxiety: a randomized clinical trial. Behav Modif. 2009 May;33(3):314-38. doi: 10.1177/0145445509331926. Epub 2009 Mar 25.
Whaley AL, Davis KE Cultural competence and evidence-based practice in mental health services: a complementary perspective. Am Psychol. 2007 Sep;62(6):563-74.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
